The nose is the subject of many sayings. A measurement could be on the nose or an object right under your nose. You may be reminded to keep your nose clean and out of another’s affairs. While often ...
The FDA broadened dupilumab's (Dupixent) approval as an add-on maintenance treatment for chronic rhinosinusitis with nasal polyps to include adolescents as well, Regeneron Pharmaceuticals and Sanofi ...
For severe chronic rhinosinusitis with nasal polyps, the novel monoclonal antibody stapokibart reduced symptoms and polyp size atop treatment with a daily intranasal corticosteroid. The polyp size ...
U.S. veterans who served in Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF) face an increased risk of developing several chronic respiratory conditions, according to new research ...
Getting a cold once or twice a few months is normal, but what about a persistently blocked nose that lingers for weeks and causes ongoing discomfort? It may be tempting to ignore, but persistent nasal ...
A new add-on therapy administered every six months targets key inflammatory pathways in asthma and chronic rhinosinusitis ...
A Canadian real-world study reveals high oral corticosteroid exposure in patients with severe chronic rhinosinusitis with ...
U.S. veterans who served in Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF) face an increased risk of developing several chronic respiratory conditions, according to new research ...
Nasal steroid sprays. Biologics. Surgery. These are some of the treatments your doctor may have recommended to manage your nasal polyps. The first-line treatment is medication management, typically ...
Approval broadens indication for TEZSPIRE to a second disease characterized by epithelial-driven inflammation AstraZeneca and Amgen’s TEZSPIRE® (tezepelumab -ekko) has been approved in the US for the ...
ReOpen was the first ever large placebo-controlled clinical trial program to demonstrate statistically significant reduction of symptoms in chronic sinusitis patients without nasal polyps Clinical ...
THOUSAND OAKS, Calif., Oct. 17, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved TEZSPIRE® (tezepelumab-ekko) for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback